MDS Virtual Congress 2021 » Parkinson's Disease and Lewy Body Dementia

Meeting: MDS Virtual Congress 2021

A single session of transcranial direct current stimulation improves the postural responses after external perturbations in both people with Parkinson’s disease fallers and non-fallers

G. Moraca, V. Beretta, D. Orcioli-Silva, M. Pereira, B. Legutke, R. Vitório, L. Gobbi (Rio Claro, Brazil)

AMP PD: Collaborating in the discovery of biomarkers to accelerate the development of therapies for Parkinson’s disease

C. Swanson-Fischer, E. Appelmans, D. Babcock, M. Bookman, D. Alonso, L. Kirsch, C. Wonders, J. Ward, S. Biswas, S. Dey, A. Singleton, H. Iwaki (North Bethesda, USA)

Arm swing instructions alter interlimb coordination but not prefrontal cortex activity of Parkinson’s disease persons.

V. Zampier, L. Mochizuki, D. Silva, V. Beretta, V. Belli, L. Gobbi (Rio Claro, Brazil)

Association between Alzheimer’s disease co-pathology and neuropsychiatric symptoms in Lewy body dementia

J. Dipane, D. Coughlin, E. Bayram (La Jolla, USA)

Cardiovascular risk factors and phenoconversion to neurodegenerative synucleinopathies in idiopathic REM sleep behavior disorder

N. Lewandowski, S. Zolfaghari, A. Pelletier, S A. Naeimi, J-F. Gagnon, M. Brillon-Corbeil, J. Montplaisir, R. Postuma (Montreal, Canada)

Central and Peripheral neurological manifestations of COVID-19 in a cohort of patients with Parkinson’s disease.

A. Vaish, B. Tyson, S. Ray (Redmond, USA)

Challenges in Implementing Relevant Exercise Interventions in Mouse Models of Parkinson’s Disease

D. Grogan, H. Skelton, J. Rubiano, C. Gutekunst, R. Gross (Augusta, USA)

Development of the CONSORTIUM FOR GLOBAL DIVERSITY IN PARKINSON’S DISEASE (CDG-PD) Patient Database

J. Bajwa, M. Salari, S. Khan, H. Amer, A. Al-Qassabi, A. Habib, J. Habib, M. Abu Al-Melh, M. Abu Snineh, Q. Un Nisa, S. Zaidi, A. Dahshan, W. Regragui, J. Ahmed, H. Shehata, I. Hashmat, N. Ullah Bullo, S. Om Mittal, T. Mohammad, W. Kamel, T. Houyam, S. Eljaffery, R. Rajan, M. Farghal, F. Abdulla, Z. Al-Daajani, P. Schmidt, H. Khalil (Riyadh, Saudi Arabia)

Differentiating Gait Impairments in Early Parkinson’s Disease and Early Dementia with Lewy Bodies

K. Mathias, A. Pinto, E. Matar, J. Phillips, S. Lewis, K. Ehgoetz Martens (Waterloo, Canada)

Effects of white matter hyperintensities, neuropsychiatric symptoms, and cognition on activities of daily living: Differences between Dementia with Lewy Bodies and Alzheimer’s disease

S. Mirza, U. Saeed, J. Ramirez, N. Herrmann, S. Black, M. Masellis (Toronto, Canada)

Elucidating multimodal endophenotypes of APOE-ε4 in α-synucleinopathies

U. Saeed, SS. Mirza, SE. Black, M. Masellis (Toronto, Canada)

Event-related oscillations in patients with Dementia with Lewy Bodies with and without mutations in the GBA gene

Y. Rosenblum, N. Bregman, A. Thaler, A. Orr-Urtreger, N. Giladi, A. Mirelman, T. Shiner (Tel Aviv, Israel)

Investigation of the consultation status and clinical symptoms of patients with Parkinson’s disease after the spread of COVID-19

M. Iijima, R. Morimoto, K. Kitagawa (Tokyo, Japan)

Long-term cognitive and motor decline across the spectrum of Lewy body disease.

MC. Gonzalez, J. Maple-Grødem, D. Tovar‐rios, CH. Williams-Gray, M. Camacho, L. Forsgren, D. Bäckström, R. Lawson, AD. Macleod, CE. Counsell, C. Paquet, C. Falup-Pecurariu, F. Blanc, A. Padovani, C. de Lena, F. D'Antonio, G. Alves, D. Aarsland (Stavanger, Norway)

Machine Learning (ML) Prediction of Parkinson’s Disease (PD) Risk and Nigral Neuron Density

I. Karabayir, L. Butler, S. Goldman, R. Kamaleswaran, F. Gunturkun, R. Davis, GW. Ross, H. Petrovitch, K. Masaki, C. Tanner, G. Tsivgoulis, A. Alexandrov, O. Akbilgic (Maywood, USA)

Motor and non-motor effects of mevidalen in Lewy Body Dementia as measured by the Movement Disorder Society’s Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)

K. Biglan, L. Munsie, K. Svensson, P. Ardayfio, M. Pugh, J. Sims, M. Brys (Indianapolis, USA)

Non-Tremor Motor Dysfunction is Associated with AD Biomarkers in Lewy Body Dementias

I. Walker, S. Shaw, S. Vaishnavi, D. Wolk, N. Dahodwala, J. Morley, J. Duda, A. Chen-Plotkin, A. Siderowf, L. Shaw, E. Lee, J. Trojanowski, M. Grossman, D. Weintraub, D. Irwin (Philadelphia, USA)

Parkinson’s disease patients may be at higher risk of Covid-19 mortality

M. Salari, M. Etemadifar, S. Tehrani Fateh, Z. Aminzade (Tehran, Islamic Republic of Iran)

Perampanel inhibits α-synuclein transmission in Parkinson’s disease models

J. Ueda, N. Uemura, R. Takahashi (Kyoto, Japan)

Physical activity and subjective perception of PD symptoms during COVID-19 lockdown: a clinical audit

V. Foster, J. Pasquini, N. Pavese (Newcastle Upon Tyne, United Kingdom)

Prevalence of Suicidal Ideation and Associated Clinical Features in Lewy Body Dementia

K. Moore, M. Armstrong, C. Jacobson, N. Gamez, B. Patel, J. Sullivan (Gainesville, USA)

Rapidly progressive dementia after MRI-guided Focused Ultrasound (MR-FUS)

JM. Perez Imbernon, S. Lopez Calvo, F. Castillo Alvarez, MT. Marti Sanchez, MM. Zambrano Vera, N. Reurich Gomez, ME. Marzo Sola (Logroño, Spain)

Risk factors for the onset of dyskinesia in patients with Parkinson’s disease exhibiting wearing-off phenomena: A 1-year observational study in Japan (J-FIRST)

T. Mishima, SW. Chiu, H. Saiki, T. Yamaguchi, Y. Shimo, T. Maeda, H. Watanabe, K. Kashihara, M. Nomoto, N. Hattori, Y. Tsuboi (Fukuoka, Japan)

The PRIME Qual study protocol: A qualitative exploration of the experiences of patients, caregivers/families and hospital/intervention staff of the PRIME Randomised Controlled Trial

H. Brant, E. Henderson, D. Gervaise-Brazier, F. Lithander, E. Tenison, S. Redwood (Bristol, United Kingdom)

« View all sessions from the MDS Virtual Congress 2021.